

Dr. Ulrich Keilholz embarked on his medical journey with a solid foundation in medicine and surgery, earning his MD degree from the University of Mainz. He furthered his academic pursuits, obtaining his doctorate from the University of Heidelberg. Specializing in internal medicine at the University of Heidelberg and later focusing on hematology and medical oncology through the Medical Association of North Baden, Dr. Keilholz demonstrated a commitment to advancing his expertise. His residency at the Department of Endocrinology and Metabolism, University of Heidelberg, solidified his clinical training. As a testament to his skills, he assumed the role of a senior consultant at the Department of Oncology and Rheumatology, University of Heidelberg. Since 1997, Dr. Keilholz has held the position of Vice President of the Department of Hematology and Oncology at Charite University Hospital. Concurrently, he has been contributing as an oncology professor at the hospital's Department of Oncology since 1998. Adding to his leadership responsibilities, he served as the Deputy Chairman of Charite Comprehensive Cancer Center. Beyond his administrative roles, Dr. Ulrich Keilholz is recognized for his active engagement in research and clinical trials, reflected in numerous publications in various medical journals.
Dr. Ulrich Keilholz is highly regarded for his extensive expertise in medical oncology and hematology, with a strong emphasis on translational cancer research and clinical trials. His work integrates internal medicine, endocrine-related oncology, and advanced systemic cancer therapies, allowing comprehensive management of complex malignancies. With decades of leadership at one of Europe’s foremost academic medical centers, he plays a key role in shaping evidence-based oncology protocols and mentoring future specialists. His commitment to innovation, research-driven care, and multidisciplinary collaboration positions him as a leading authority in modern cancer treatment and academic oncology.